Vera Therapeutics, Inc. - COMMON STOCK (VERA)

Historical Holders from Q2 2021 to Q3 2025

Symbol
VERA on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
64.3M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
65.1M
Holdings value
$1.89B
% of all portfolios
0.006%
Grand Portfolio weight change
+0%
Number of holders
172
Number of buys
98
Number of sells
-80
Average Value change %
+0%
Average buys %
+0.003%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Vera Therapeutics, Inc. - COMMON STOCK (VERA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Avoro Capital Advisors LLC 8.9% $135M 5.61M Avoro Capital Advisors LLC 31 Dec 2024
PRICE T ROWE ASSOCIATES INC /MD/ 5.7% $107M 3.67M T. Rowe Price Associates, Inc. 30 Sep 2025
Kynam Capital Management, LP 5.37% $83.4M 3.43M Kynam Capital Management, LP 30 Jun 2025
Flynn James E 5.25% $75.3M 3.35M Deerfield Mgmt, L.P. 06 Jun 2025

Institutional Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 65.1M $1.89B +$37.1M $29.06 172
2025 Q2 63.9M $1.51B +$17.3M $23.56 171
2025 Q1 62.9M $1.51B -$90M $24.02 176
2024 Q4 62.9M $2.66B +$390M $42.29 177
2024 Q3 53.5M $2.37B -$1.77M $44.20 172
2024 Q2 53M $1.92B +$57.7M $36.18 169
2024 Q1 51.3M $2.21B +$474M $43.12 157
2023 Q4 41.3M $636M +$44.8M $15.38 93
2023 Q3 39.3M $538M +$9.62M $13.71 84
2023 Q2 38.1M $612M +$42.6M $16.05 76
2023 Q1 37.4M $290M +$138M $7.76 69
2022 Q4 21.3M $413M -$7.25M $19.35 57
2022 Q3 21.5M $459M +$19.1M $21.31 55
2022 Q2 20.4M $278M +$7.85M $13.61 49
2022 Q1 19.5M $457M +$130M $23.49 49
2021 Q4 14.1M $375M +$10.5M $26.72 37
2021 Q3 14.7M $252M +$4.17M $17.35 30
2021 Q2 14.5M $186M +$186M $13.25 21